Articles by Disease (Neuroblastoma)

New Approaches to Target Cancer Stem Cells: Current Scenario

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14
Page: 20-34
Author(s): Mayank Bashyal Insan and Vikas Jaitak

The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14
Page: 46-51
Author(s): Alicia M. Waters and Elizabeth A. Beierle

Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14
Page: 29-34
Author(s): Wen-Ling Yao, Bor-Sheng Ko, Tzu-An Liu, Shu-Man Liang, Chia-Chia Liu, Yi-Jhu Lu, Shean-Shong Tzean, Tang-Long Shen and Jun-Yang Liou

Editorial (Thematic Issue: Focal Adhesion Kinase and Cross-Linked Signaling In Cancer)

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14
Page: 2-2
Author(s): Vita M. Golubovskaya

MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14
Page: 18-28
Author(s): Vita M. Golubovskaya, Brittany Sumbler, Baotran Ho, Michael Yemma and William G. Cance

The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14
Page: 9-17
Author(s): Grace Huang, Baotran Ho, Jeffrey Conroy, Song Liu, Hu Qiang and Vita Golubovskaya

Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Clinical Trials: Potential Effects of Inserted Sequences

Journal: Current Gene Therapy
Volume: 13
Page: 395-412
Author(s): Eric van den Akker, Cecile J.B. van der Vlugt, Diederik A. Bleijs and Hans E. Bergmans